Beyfortus 50 mg/100 mg

    Beyfortus 50 mg/100 mg

    S4


    1. What BEYFORTUS is and what it is used for

    What BEYFORTUS is

    BEYFORTUS is a medicine given as an injection to protect babies against respiratory syncytial virus (RSV). RSV is a common respiratory virus that usually causes mild symptoms comparable to the common cold. However, especially in babies and older adults, RSV can cause severe illness, including bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) that may lead to hospitalisation or even death. The virus is usually more common during the winter.

    BEYFORTUS contains the active ingredient nirsevimab which is an antibody (a protein designed to attach to a specific target) that attaches to a protein that RSV needs to infect the body. By attaching to this protein, BEYFORTUS blocks its action, thereby stopping the virus from entering and infecting human cells.

    What is BEYFORTUS used for

    BEYFORTUS is a medicine to protect your child from getting RSV disease.

    2. What you need to know before your child is given BEYFORTUS

    You must not receive BEYFORTUS if:

    • Your child should not use BEYFORTUS if he or she is allergic (hypersensitive) to nirsevimab or any of the other ingredients of BEYFORTUS (listed in section 6). If your child shows signs of a severe allergic reaction contact the doctor immediately.

    Warnings and precautions

    Tell your doctor or seek medical help immediately if you notice any signs of an allergic reaction, such as:

    • difficulty breathing or swallowing
    • swelling of the face, lips, tongue or throat
    • severe itching of the skin, with a red rash or raised bumps

    Talk to your health care provider before your child is given BEYFORTUS if they have low numbers of blood platelets (which help blood clotting), a bleeding problem or bruise easily or if they are taking an anticoagulant (a medicine to prevent blood clots).

    Children and adolescents

    Do not give BEYFORTUS to children between the age of 2 and 18 years of age because it has not been studied in this group.

    Other medicines and BEYFORTUS:

    Always tell your health care provider if you are taking any other medicine. (This includes complementary or traditional medicines.) Please consult with your doctor, pharmacist or health care provider for advice if you need to take any other medicines. BEYFORTUS is not known to interact with other medicines. BEYFORTUS may be given at the same time as vaccines that are part of the national immunisation program.

    Pregnancy and breastfeeding

    BEYFORTUS is only intended for use in newborns and infants.

    Driving and using machines

    BEYFORTUS is only intended for use in newborns and infants.

    3. How BEYFORTUS is given

    Always use medicines exactly as your doctor or pharmacist has instructed you. You should check with your doctor or pharmacist if you are unsure. Do not share medicines prescribed for you with any other person.

    BEYFORTUS is given by a doctor, pharmacist or nurse as a single injection in the muscle. It is usually given in the outer part of the thigh. The recommended dose is 50 mg for children weighing less than 5 kg and 100 mg for children weighing 5 kg or more.

    BEYFORTUS should be given before the RSV season. The virus is usually more common during the winter (known as the RSV season). If your child is born during the winter, BEYFORTUS should be given after birth.

    If your child is to have a heart operation (cardiac surgery), he or she may be given an extra dose of BEYFORTUS after the operation to ensure they have adequate protection over the remainder of the RSV season.

    If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

    If your child is given more BEYFORTUS than he or she should BEYFORTUS will be administered to your child by your doctor or nurse. If your child is accidentally given too much (an overdose), your doctor will treat and monitor your side effects.

    4. Possible side effects

    BEYFORTUS can have side effects. Not all side effects reported for BEYFORTUS are included in this leaflet. Should your child’s general health worsen or if your child experience any untoward effects while he/she is receiving BEYFORTUS, please consult your doctor, pharmacist or other health care provider for advice.

    If any of the following happens to your child while receiving BEYFORTUS, tell your doctor immediately:

    • swelling of the hands, feet, ankles, face, lips and mouth or throat, which may cause difficulty in swallowing or breathing
    • rash or itching
    • fainting

    These are all very serious side effects. If your child has them, they may have had a serious reaction to BEYFORTUS. Your child may need urgent medical attention.

    Tell your doctor if you note any of the following side effects in your child:

    Uncommon side effects:

    • rash
    • injection site reaction (i.e. redness, swelling, and pain where the injection is given)
    • fever

    If you notice any side effects not mentioned in this leaflet, please inform your doctor, nurse or other health care provider.

    Reporting of side effects

    If you get side effects, talk to your doctor or pharmacist. You can also report side effects to:

    • The Pharmacovigilance Unit at Sanofi: [email protected] (email), https://ae.reporting.sanofi/ (web portal) or +27 11 256 3700 (tel), or
    • SAHPRA via the “6.04 Adverse Drug Reaction Reporting Form”, found online under SAHPRA’s publications: https://www.sahpra.org.za/Publications/Index/8

    By reporting side effects, you can help provide more information on the safety of BEYFORTUS.

    5. How to store BEYFORTUS

    Store all medicines out of reach of children. Store in a refrigerator (2 °C – 8 °C). Do not freeze. Keep the pre-filled syringe in the outer carton to protect from light. Do not shake or expose to direct heat. Do not use after the expiry date stated on the label and carton. Return all unused medicine to your pharmacist. Do not dispose of unused medicine in drains or sewerage systems (e.g. toilets). Any waste material should be disposed of in accordance with local requirements.

    Important Disclaimer

    The Beyfortus 50 mg/100 mg professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Somayeza exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Somayeza serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

    Unlock Exclusive Features

    To ensure the fastest, most secure experience, this feature is exclusively available on the free Somayeza mobile app.

    Download the App to Unlock
    On This Page
    Beyfortus 50 mg/100 mg
    1/-
    Official PDF leaflet

    The patient information text is available above. Load the original PDF only when you need it.

    Somayeza AI
    Hello! I am your medical reading assistant. What would you like to know about this patient information leaflet?
    Successfully Stashed! 💊

    This patient information leaflet has been safely stored in your digital medical cabinet. No prescription needed to view it later!

    View My Favourites